Mannkind (MNKD) Receivables - Other (2010 - 2023)

Mannkind (MNKD) reported Receivables - Other of $400000.0 for Q3 2023, down 33.33% year-over-year from $600000.0 in Q3 2022, and up 100.0% quarter-over-quarter from $200000.0 in Q2 2023.

Mannkind (MNKD) Receivables - Other (2010 - 2023) Analysis & Trends

Mannkind (MNKD) has 9 years of Receivables - Other data on file, last reported at $400000.0 in Q3 2023.

  • Receivables - Other for Q3 2023 came in at $400000.0, down 33.33% year-over-year; the trailing twelve-month figure through Sep 2023 was $400000.0 (down 33.33% YoY), and the FY2021 annual result was $255000.0, changed N/A from the prior year.
  • Receivables - Other rose to $400000.0 in Q3 2023 per MNKD's latest filing, from $200000.0 in the prior quarter.
  • Over five years, Receivables - Other peaked at $5.0 million in Q2 2019 and troughed at $200000.0 in Q2 2023.
  • A 4-year average of $1.0 million and a median of $450000.0 in 2022 frame the typical range for Receivables - Other.
  • On a YoY basis, Receivables - Other climbed as much as 40.0% in 2023 and fell as far as 50.0% in 2023.
  • A 4-year view of Receivables - Other shows it stood at $5.0 million in 2019, then tumbled by 94.0% to $300000.0 in 2021, then jumped by 100.0% to $600000.0 in 2022, then tumbled by 33.33% to $400000.0 in 2023.
  • Business Quant data shows MNKD's Receivables - Other at $400000.0 in Q3 2023, $200000.0 in Q2 2023, and $700000.0 in Q1 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn

Historic Data

Download Data
DateValue
Sep 30, 2023 400,000.00
Sep 30, 2023 400,000.00
Jun 30, 2023 200,000.00
Jun 30, 2023 200,000.00
Mar 31, 2023 700,000.00
Mar 31, 2023 700,000.00
Sep 30, 2022 600,000.00
Sep 30, 2022 600,000.00
Jun 30, 2022 400,000.00
Jun 30, 2022 400,000.00
Mar 31, 2022 500,000.00
Mar 31, 2022 500,000.00
Dec 31, 2021 300,000.00
Dec 31, 2021 300,000.00
Jun 30, 2019 5.00 Mn
Jun 30, 2019 5.00 Mn
Sep 30, 2014 803,000.00
Sep 30, 2014 803,000.00
Sep 30, 2013 298,000.00
Sep 30, 2013 298,000.00